Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Dec
2
2020
Ohio Pharmacist Duties to Report: Ohio Board Issues Updated Guidance Dinsmore & Shohl LLP
Dec
1
2020
Survey Evidence in Amended Complaint Does Not Add Enough Juice to Save “Natural” Claims Against Mott’s Apple Products Proskauer Rose LLP
Dec
1
2020
Class Action Lawsuit Alleges that Diestel Turkey Ranch Turkeys Are Factory Farmed and Falsely Advertised Keller and Heckman LLP
Nov
30
2020
EPA Releases Updated Draft Guidance for Biostimulant Products Beveridge & Diamond PC
Nov
30
2020
The Hain Celestial Group Briefs the Court on FDA’s Characterizing Flavor Regulations in a Motion to Dismiss the False Advertising Class Action Against ‘Organic Plus Vanilla Soy Milk’ Keller and Heckman LLP
Nov
30
2020
2020 DOJ Health Care Fraud Takedown Greenberg Traurig, LLP
Nov
26
2020
Consumer Public Interest Lawsuit Seeks 21 Million RMB for Counterfeit Trademark Sales of Starbucks in China Schwegman, Lundberg & Woessner, P.A.
Nov
25
2020
Can Employers Require Employees to Be Vaccinated Against COVID-19? Stark & Stark
Nov
25
2020
China Approves Expanded Usage for Food-Contact Substances Keller and Heckman LLP
Nov
25
2020
Oklahoma Federal Judge Refuses to Block State’s Plant-Based Labeling Law Keller and Heckman LLP
Nov
24
2020
BPA Listing as Reproductive Toxicant Under Prop 65 Upheld by Court Keller and Heckman LLP
Nov
24
2020
FDA Releases Updated Module, “Tobacco Registration and Listing Module Next Generation (TRLM NG)” for Tobacco Product Manufacturing Establishments Keller and Heckman LLP
Nov
24
2020
FDA Launches Study of Foodborne Pathogens in Partnership with Californian Stakeholders Keller and Heckman LLP
Nov
23
2020
Los Angeles County Restricts In-Person Dining Due to Surge in COVID-19 Cases Sheppard, Mullin, Richter & Hampton LLP
Nov
23
2020
Pennsylvania Court Affirms Unemployment Benefits for Medical Marijuana User Jackson Lewis P.C.
Nov
23
2020
Transatlantic Trade: US and Europe – Week of November 16, 2020 Squire Patton Boggs (US) LLP
Nov
23
2020
FDA Issues Final Guidance for Industry and FDA Staff on Publicizing Lists of Retailers That May Have Received Certain Recalled Food Keller and Heckman LLP
Nov
23
2020
A Record-Breaking Year in Digital Health Investments: Key Takeaways | HTLH GoLive Webinar
Nov
21
2020
New York Announces CBD Product Guidelines Hinch Newman LLP
Nov
20
2020
COVID-19 Weekly Newsletter: Vaccine Update, Thanksgiving Guidance Faegre Drinker
Nov
20
2020
H.R. 4712: A “Narrowly Tailored” Obligation Under the Orphan Drug Act? Proskauer Rose LLP
Nov
20
2020
FDA Releases New Outbreak Investigation Table Keller and Heckman LLP
Nov
20
2020
Florida Department of Health Issues 5 Notices of Emergency Rules Related to Medical Marijuana Treatment Centers Greenberg Traurig, LLP
Nov
19
2020
New York State Drafts Rules for CBD in Foods and Dietary Supplements Keller and Heckman LLP
Nov
19
2020
FDA Adds Thirteen New Substances to its Inventory of Effective FCS Notifications Keller and Heckman LLP
Nov
18
2020
Tripping on Hallucinogenics in Oregon: Two New Measures Decriminalize Certain Narcotics and Legalize Psilocybin Therapy Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Nov
18
2020
New Jersey Restrictions Return for Bars and Restaurants as COVID-19 Cases Increase Norris McLaughlin P.A.
Nov
18
2020
Addressing COVID-19 Vaccine Supply Chain Challenges Squire Patton Boggs (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins